COO and VP of HR · Perspective Therapeutics, Inc. (CATX)

Jennifer Streeter

A named executive officer of Perspective Therapeutics in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$266,349

Salary $256,672Stock awards $0

FY2020: $312,285

2nd of 3 named executive officers at Perspective Therapeutics by FY2021 total.

3 named officers on file for Perspective Therapeutics, FY2021

Jennifer Streeter’s pay file — $29

  • 2 fiscal years of pay, line by line
  • CATX’s disclosed peer group of 25 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Perspective Therapeutics’s whole pay program stands against its peers

  • Perspective Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CATX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 25, 2021 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Jennifer Streeter’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Jennifer Streeter compensation by year

Perspective Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Perspective Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$214,565$256,672
Bonus$0$0
Stock awards$0$0
Option awards$59,220$0
Non-equity incentive$38,500$9,677
Pension and deferred compensation$0$0
All other$0$0
Total$312,285$266,349

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Perspective Therapeutics, Inc. DEF 14A filed October 25, 2021, accession 0001437749-21-024237, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Perspective Therapeutics, Inc. filed document, accession 0001437749-21-024237. Every figure is read from that document and cited to the page and table it appears in. Filed October 25, 2021.

$312K
$266K
FY20
FY21
SalaryNon-equity incentiveOption awards

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
Option75,000—$0.61
Option37,500—$0.43

Per the Outstanding Equity Awards at Fiscal Year-End table in Perspective Therapeutics, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

1 Form 4 line since the FY2021 proxy (filed October 25, 2021)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2023-06-12Grant or award derivative—500,000$0.001,722,500

The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Perspective Therapeutics’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Lori WoodsCEO and Director$371,195
Jennifer Streeter · this pageCOO and VP of HR$266,349
William CavanaghCRDO$253,339

The full Perspective Therapeutics compensation record

free company brief

This page is one person within Perspective Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Perspective Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Perspective Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Jennifer Streeter's compensation dossier · One-time report. No refunds.